PRO-DEX, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
PRO-DEX, INC. (PDEX) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $7.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2026-09-03
- PRO-DEX, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2026 was $7.00K.
- PRO-DEX, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2025 was -$13.00K, a 130.95% decline from fiscal 2024.
- PRO-DEX, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $42.00K, a 74.55% decline from fiscal 2023.
- PRO-DEX, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $165.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2026-06-30 | $7.00K 10-K · filed 2026-09-03 | |
| 2025-06-30 | -$13.00K 10-K · filed 2026-09-03 | $13.00K 10-K · filed 2025-09-04 |
| 2024-06-30 | $42.00K 10-K · filed 2025-09-04 | |
| 2023-06-30 | $165.00K 10-K · filed 2024-09-05 | |
| 2022-06-30 | -$46.00K 10-K · filed 2023-10-13 | |
| 2021-06-30 | -$22.00K 10-K · filed 2022-09-08 | |
| 2020-06-30 | $3.00K 10-K · filed 2021-09-09 | |
| 2019-06-30 | -$43.00K 10-K · filed 2020-09-10 | |
| 2018-06-30 | $7.00K 10-K · filed 2019-09-12 | |
| 2017-06-30 | -$7.00K 10-K · filed 2018-09-13 | |
| 2016-06-30 | $2.00K 10-K · filed 2017-09-14 | |
| 2015-06-30 | -$1.00K 10-K · filed 2016-09-15 | $1.00K 10-K · filed 2015-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |